Patent · US Active

Pharmaceutical aerosol product for administration by oral or nasal inhalation

US11007150B2 · kind B2 · utility

2Cited by

9References

16Claims

0Family size

Assignee

Covis Pharma GmbH · CH

Inventors

Helgert Müller · Radolfzell, DE
Renate Engelstätter · Allensbach, DE
Ulrich Bildmann · Hilzingen, DE
Andrea Bauer · North Reading, US
Paul McGlynn · Northborough, US

Key dates

Filing date	Aug 13, 2012
Grant date	May 18, 2021
Priority date	—
Expiry date	Aug 13, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M15/009
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The inventive subject matter relates to a pharmaceutical aerosol product suitable for administration by oral or nasal inhalation and its use in the treatment of respiratory diseases, in particular in the treatment of children.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.